Technology
Health
Biotechnology

Bicycle Therapeutics

$7.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.14 (1.84%) Today
+$0.13 (1.71%) As of 5:13 PM EDT after-hours

Why Robinhood?

You can buy or sell BCYC and other stocks, options, ETFs, and crypto commission-free!

About BCYC

Bicycle Therapeutics plc American Depositary Shares, also called Bicycle Therapeutics, is a holding company, which engages in the development of biopharmaceuticals. It focuses on developing a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Read More The firm utilizes its novel and proprietary phage display screening platform to identify bicycles. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.

Employees
60
Headquarters
Cambridge, Cambridgeshire
Founded
2009
Market Cap
137.28M
Price-Earnings Ratio
Dividend Yield
Average Volume
17.38K
High Today
$8.09
Low Today
$7.44
Open Price
$8.09
Volume
6.13K
52 Week High
$14.91
52 Week Low
$6.90

Collections

Technology
Health
Biotechnology
Therapy
2019 IPO
UK
Europe

BCYC Earnings

-$1.68
-$1.49
-$1.31
-$1.12
Q2 2019
Estimated
Actual
-$1.40 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.